BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 38661644)

  • 1. KIAA1429 Induces m6A Modification of LINC01106 to Enhance the Malignancy of Lung Adenocarcinoma Cells via the JAK/STAT3 Pathway.
    Xu D; Wang Z; Li F
    Crit Rev Immunol; 2024; 44(6):49-61. PubMed ID: 38848293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipid scramblase 1 acts through the IL-6/JAK/STAT3 pathway to promote the malignant progression of glioma.
    Zhou S; Xu J; Zhu Y
    Arch Biochem Biophys; 2024 Jun; 756():110002. PubMed ID: 38636689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteine and glycine-rich protein 2 is crucial for maintaining the malignant phenotypes of gliomas through its action on Notch signalling cascade.
    Liu L; Li F; Zhang L; Cheng Y; Wu L; Tie R; Jiang X; Gao W; Liu B; Wei Y; Chang P; Xu J; Zhao H; Zhang L
    Toxicol Appl Pharmacol; 2024 Jun; 487():116969. PubMed ID: 38744347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIAA0040 enhances glioma growth by controlling the JAK2/STAT3 signalling pathway.
    He J; Xue K; Fan F; Li L; Rao X; Liu W; Nie C
    J Cell Mol Med; 2024 Apr; 28(8):e18332. PubMed ID: 38661644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of microRNA-133a and downregulation of connective tissue growth factor suppress cell proliferation, migration, and invasion in human glioma through the JAK/STAT signaling pathway.
    Zhang P; Chen FZ; Jia QB; Hu DF
    IUBMB Life; 2019 Dec; 71(12):1857-1875. PubMed ID: 31381269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTR9-mediated JAK2/STAT3 pathway promotes the proliferation, migration, and invasion of human glioma cells.
    Xu Y; Chen J; He G; Zhang Y
    J Clin Lab Anal; 2021 Sep; 35(9):e23943. PubMed ID: 34369006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA HOST2 Promotes Epithelial-Mesenchymal Transition, Proliferation, Invasion and Migration of Hepatocellular Carcinoma Cells by Activating the JAK2-STAT3 Signaling Pathway.
    Wu Y; Yuan T; Wang WW; Ge PL; Gao ZQ; Zhang G; Tang Z; Dang XW; Zhao YF; Zhang JY; Jiang GZ
    Cell Physiol Biochem; 2018; 51(1):301-314. PubMed ID: 30453302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GOLPH3 promotes glioma progression via facilitating JAK2-STAT3 pathway activation.
    Wu S; Fu J; Dong Y; Yi Q; Lu D; Wang W; Qi Y; Yu R; Zhou X
    J Neurooncol; 2018 Sep; 139(2):269-279. PubMed ID: 29713848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircTCF25 serves as a sponge for miR-206 to support proliferation, migration, and invasion of glioma via the Jak2/p-Stat3/CypB axis.
    Yin H; Wang H; Wang M; Yan Y; Dong Q; Li Q; Liu Y; Wang X; Guo T; Niu L; Zhang H; Wang B; Yao X; Yuan G; Pan Y
    Mol Carcinog; 2022 Jun; 61(6):558-571. PubMed ID: 35384084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRMT6 methylation of STAT3 regulates tumor metastasis in breast cancer.
    Chen Q; Hu Q; Chen Y; Shen N; Zhang N; Li A; Li L; Li J
    Cell Death Dis; 2023 Oct; 14(10):655. PubMed ID: 37813837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-Associated Macrophage-Derived Exosomal LINC01232 Induces the Immune Escape in Glioma by Decreasing Surface MHC-I Expression.
    Li J; Wang K; Yang C; Zhu K; Jiang C; Wang M; Zhou Z; Tang N; Wang Q; Wang S; Shu P; Yuan H; Xiong Z; Li J; Liang T; Rao J; Wang X; Jiang X
    Adv Sci (Weinh); 2023 Jun; 10(17):e2207067. PubMed ID: 37097629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma.
    Jiang C; Zhou Y; Yan L; Zheng J; Wang X; Li J; Jiang X
    Front Oncol; 2023; 13():1051641. PubMed ID: 36845744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNF7 promotes glioma growth via the PI3K/AKT signalling axis.
    Tang N; Zhu K; Jiang C; Xiong Z; Wang Q; Li J; Xu W
    J Cell Mol Med; 2023 Jan; 27(2):277-286. PubMed ID: 36578229
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.